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ABSTRACT
Whey proteins are mainly a group of small globular proteins. Their structures can
be modified by physical, chemical and other means to improve their functionality.
The objectives of this study were to investigate the effect of radiation on proteinprotein interaction, microstructure, and microbiological properties of whey
protein-water solutions. Whey protein isolate (WPI) solutions (27-36% protein)
were treated with different dosages (10-35 KGy) of gamma radiation. The protein
solutions were analyzed for viscosity, turbidity, soluble nitrogen, total plate count,
and yeast and mold counts. The interactions between whey proteins were also
analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDSPAGE), and scanning electron microscopy (SEM). The viscosity of protein
solution (27%, w/w) was increased from 2.19 for the control to 4.78 mPa·s for the
sample treated at 25 KGy, respectively, and viscosity also increased during storage
at 23°C. The soluble nitrogen (10%, w/w) was decreased from 100% to 54.7% for
control and the sample treated at 35 KGy. The effects of gamma radiation and
storage time on viscosity of whey protein solutions were significant (p<0.05).
Radiation treatment had significant impact on soluble nitrogen of whey protein
solutions (p<0.05). SDS-PAGE results showed that intensity of the major protein
band was reduced and it had smeared appearance for the treated samples and
photographs of SEM also showed that protein-protein interactions induced by
gamma radiation in the model system.
Key works: whey protein isolate, gamma radiation, sterilize, interaction.
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CHAPTER 1: COMPREHENSIVE LITERATURE REVIEW

1.1 INTRODUCTION
Sealing wounds and stopping hemorrhages on the battleground have
been going on for thousands of years. From then on, the suture was created and
has become a common way to treat wounds in modern medical treatment.
Currently, there are various types of absorbable and non-absorbable sutures of
different sizes with different-size needles; and with more than forty different
combinations are being used to close wounds and incisions (Quinn 2005).
However, there are several manifest disadvantages to dealing with wounds by
suture, such as high infection rate, physical pain, and long healing time.
Therefore, alternative methods to suture have been evaluated including
adhesive tapes, gums, and tissue adhesives.
Given the shortcomings of some wound closure devices, interest in
tissue adhesives has grown in the last half-century and especially in the last
decades (Quinn 2005). Tissue adhesives have been used to close wounds and
stop bleeding. Substantial advantages make tissue adhesives widely used in
clinics. During some surgeries, tissue adhesives can be used as a way to seal
the vascular system and some organs like the stomach. The use of proteins as
a component in tissue adhesives has been previously studied and whey protein
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has potential to be used as a functional polymer component for adhesives.
Whey is the byproduct of cheese-making. Globally, dry whey and
whey proteins (protein content 80% and below) exports totaled nearly 1.27
million metric tons in 2010, up 12.5% versus 2009 exports (Horizons 2012).
However, the total amount of whey is not being fully used every year. The
main utilizations of whey are for animal feed, fertilizers, or as an ingredient
for human foods. The United States is one of the world largest whey
producers, which also produced fluid whey not fully used by human and
animals. Disposal of whey by dumping into rivers was frequently used in the
United States before environmental regulations were enforced (Cryan 2001,
Onwulata 2008). Preventing pollution caused by disposal of whey and
recovering its nutrient value have been two major factors of interest of using
whey for decades. At the University of Vermont’s research lab, whey protein
was used for formulation of wood and paper adhesives. It would be valueadded applications of whey protein for developing other products

1.2 WHEY PROTEINS
1.2.1 Whey Production
Milk and milk products are used extensively because of their functional
and nutritional properties. Milk provides diversified nutritional needs for
human. The approximate composition of cow’s milk is shown in Table 1
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(Potter 1995). Historically, milk proteins were extensively demanded for
human health benefits. Caseins, representing about 80% of the total nitrogen
(Fox 1989), and whey proteins are the two major proteins in bovine milk.
Table 1. Components of Cow’s Milk
Components
Water
Fat
Protein
Lactose
Ash
Total solids

%
87.1
3.9
3.3
5.0
0.7
12.9

Whey is obtained from separating casein from bovine milk during
cheese manufacture. Whey can be divided into two categories: sweet whey (a
minimum pH of 5.6) and acid whey (a maximum pH of 5.1). Whey contains
many types of proteins and essential amino acids for human. Yet without being
fully utilized, currently whey is an ample and burdensome byproduct for the
U.S. dairy industry. Whey is as an essential ingredient in the modern food
industry due to its high concentration of protein, amino acids, and minerals,
which are all high quality of nutrients for human consumption. Whey proteins
are used in the manufacture of diet supplements, infant formuleverages, bakery
products, and sports drinks.
The utilization of whey and whey proteins has been in existence since
antiquity. Portions of whey were used for humans and the rest was used for
livestock forage and fertilizer. Even though the functional and nutritive values
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of whey have been known for decades, whey as a byproduct is still not fully
used. A substantial amount of whey is simply discarded every year. Whey has
a biochemical oxygen demand (BOD) of 35,000-45,000 g/liter, and 100 liters
of whey has a polluting strength equivalent to the sewage produced by 45
people (Fox 1982). However, proteins and nutrients in whey are too valuable
to be unutilized.
Whey concentrating and drying are the two innovations to obtain the
nutrients. The long-tube multiple-effect evaporator and the spray drier were
the two important inventions in the early twentieth century in the whey
industry and the spray drier is still used in modern dairy industry. Five types
of membrane filtration (ultrafiltration, microfiltration, electrodialysis,
nanofiltration, and reverse osmosis) were developed and applied to obtain a
dry (<5% moisture content) product (Onwulata 2008). With the help of these
processes, it is now possible and simple to obtain different concentrations of
whey protein.
1.2.2 Whey Protein Concentrate (WPC) and Whey Protein Isolate (WPI)
WPCs and WPI are important whey products because of their high
concentrations of proteins and wide usage. WPC can be obtained from
ultrafiltration (UF) of whey. WPC may contain from 20 to 90% protein; WPC
with 35% protein (WPC-35) is a common product (Onwulata 2008). WPI has
a high concentration of protein (at least 90%) from whey. The lactose in WPI
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is totally separated. WPC 80 production was 86,000 tons in 2011 and WPI
production was expected to reach 27,600 metric tons in 2011 in the United
States (Horizons 2012).
The interest of using WPC and WPI is still growing for human health
and benefits. Beneficial factors of WPC and WPI in food applications include
its high protein and amino acid content; lack of pathogens, toxic compounds,
and antinutritional factors; and abundant availability (Onwulata 2008). In the
medicinal field and nutritional demands, products such as WPI supplements
have also been developed from high concentrations of whey proteins using
the processes of membrane filtrations.
1.2.3

Whey Protein Chemistry
The nutritive components of whey have interested scientists for

centuries. Lactalbumin is the solid got from heating whey. Lactoglobulin
which was a precipitate showed in research to form by the addition of
magnesium sulfate or ammonium sulfate at low pH (Creamer 2003, Onwulata
2008). Subsequently, bovine serum albumin, immunoglobulin, and other
proteins were identified. Whey proteins are generally comprised of βlactoglobulin (β-LG) (50%), α-lactalbumin (α-LA) (20%) (Fox 1989), bovine
serum albumin (BSA) (6%), immunoglobulins (Ig) (10%), and proteosepeptones component glycomacropeptides (12%) (Onwulata 2008). Whey also
contains lactoferrin (LF) and lactoperoxidase (LP), but the concentrations are
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at very low levels. There are other minimal components in whey proteins that
are remained from the cheese making process. Table 2 shows the compounds
and functions of whey proteins in bovine milk (Wit 1998).
Table 2. Compounds and Functions of Whey Proteins in Cow’s Milk
Whey protein
Whey
Biological function
contribution
Major
(g/L of milk)
For the calf
(Pro)vitamin A
β-LG
3.2
Transfer
α-LA
1.2
Lactose synthesis
BSA
0.4
Fatty acid transfer
IgG
0.8
Passive immunity
Bioactive
General
LF
0.2
Bacteriostatic agents
LP
0.03
Antibacterial agent
Enzymes (>50)
0.03
Health indicators
Proteose-peptones
≥1
Even though WPC and WPI have higher protein concentrations, the
amounts of various protein components such as β-LG and bovine serum
albumin are not significantly changed.
WPC and WPI contain more than half of β-LG, so the properties of βLG approximately reflect the properties of WPCs and WPIs. BSA and α-LA
are the other two important proteins. β-LG and α-LA will be fractionated first
and easily from whey proteins. Due to the binding ability and affinity for
retinol of β-LG, it has the function of vitamin A transportation. The biological
function of α-LA is to act as a specifier protein for lactose synthetase in the
formation of lactose from galactose and glucose and α-LA is a calcium
metallo-protein which Ca2+ may have a second messenger function for the
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binding of α-LA to target proteins (Stuart 1986, Fox 1989). Bovine serum
albumin (BSA), is a well-known transport protein for insoluble fatty acids in
the blood circulatory system (Spector 1975, Fox 1989). Typical relative
abundances, isoelectric points, molecular weights and denaturation
temperatures of these proteins are listed in Table 3 (Wit 1981, Kinsella 1989).
There are also many enzymes in whey and other minimal proteins.
Table 3. Physical Characteristics of the Major Whey Proteins
Protein
β-LG
α-LA
BSA
Immunoglobulins

pI
M.W.
5.2
18400
4.814200
5.1
66000
4.8155.1
96×104
5.56.8
a
Td represent the temperature of denaturation.

%
60
22
5.5
9.1

Tda
78
62
64
72

1.2.4 Structures of Whey Proteins
Whey proteins are mainly groups of small globular proteins. The
primary structure of protein is a peptide chain and amino acid residues (Figure
1) (Walstra 1999). Several amino acids can interact to form a linear peptide
chain. Proteins are long chains that most are comprised of more than 100
amino acid groups. According to the primary structure, hydrogen bonds and
hydrophobic interactions with a peptide chain can fold to obtain a specific
structure.
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Figure 1. Peptide Chain
The secondary and tertiary structures show a high degree of
organization with a great proportion of beta sheets (43-50% of the residues)
and only 10-15% of a helix and 15-20% of beta turn (Damodaran 1997).
Domains are used to describe the tertiary structure of protein molecules. The
tertiary structures of β-LG and α-LA are shown in Figure 2 (Damodaran 1997).
These molecules have their own distinguishing areas and functions. For
example, domains have far-reaching impact on the denaturation. BSA has three
specific domains for metal ion binding, lipid binding, nucleotide binding
(Peters 1977, Fox 1989). The secondary and tertiary structures are important
for protein functions so that the changes of these structures may cause the
significant functional changes of protein properties.
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Figure 2. Tertiary Structures of β-LG (A) and α-LA (B).
1.2.5 Functional Properties of Whey Protein
Whey protein structures can be modified by physical, chemical and
other means to improve their functionality. Factors including pH and ionic
strength may have impact on the conformation of proteins.
Denaturation of proteins means that the primary structure does not
change but secondary and tertiary structures will be changed considerably.
High pH, high temperature, some salts and other chemicals can be used for
the denaturation of proteins. Occasionally, denaturation may be reversed to
the original condition, but if aggregation occurs, it is an irreversible
unfolding. Whey proteins can be aggregated and gelled when being thermal
treated. The protein structures and properties may start to change at the
temperature up to 60 °C and irreversible changes require higher temperatures
9

(above 70 °C). Color, viscosity, pH, solubility, and other physicochemical
changes may occur caused by denaturation of whey proteins
Protein-protein interactions occur at high temperature and these
reactions can crosslink peptide chains and cause polymerization. These
changes also include changes in primary structure. β-LG dissociates into
monomers and the non-covalent bonds are first to be cleaved and the SH
groups are activated to form disulfide bridges (Sienkiewicz 1990). At higher
temperature, proteins polymerize into larger molecular weight.
Gamma radiation can be used to sterilize WPI solutions without
denaturing whey proteins by thermal treatment. However, there are some other
side effects including gelation. Gelation occurs after gamma radiation and all
the WPI solutions become more opaque. Except radiation, other factors like
heat treatment, storage temperature, and total solids can also affect the degrees
of gelation.
Gelation begins with protein unfolding interactions. Ionic and
hydrophobic interactions and/or covalent disulfide bonding are critical
intermolecular interactions (to a varying extent) for gel formation (Fox 1989).
As the gelation continues, aggregation occurs to form a gel. A schematic
representation of the gelation mechanism is shown in Figure 3 (Onwulata
2008). Gelation of whey proteins has its industrial values. For example, cheese
curd is formed with cold gelation.
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Figure 3. A Schematic Representation of Gelation Mechanism
Due to the functional and nutrient values of whey proteins, it is
necessary and also possible to look into additional high value added
applications of whey proteins. Moreover, WPI is cost inexpensive and readily
available in the United States.
In the functional foods laboratory of the University of Vermont, we
developed many whey protein products, like wood adhesives, paper adhesives,
and stick glues. If we could develop a protein-based tissue adhesive, it would
be a more valuable application of whey protein isolate.

1.3 TISSUE ADHESIVES
1.3.1 Overview of Wound Closure
People in ancient time had the knowledge to deal with trauma or
incision caused by injuries. Ancient Chinese people used medicinal herbs
wrapped in sackcloth to treat bleeding. It was fatal for those with deep wound
when they could not get a necessary treatment. Then the suture was created to
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treat wounds and hemorrhage by sewing. Suture technique has become the
common and basic method for closing wounds nowadays. Absorbable sutures
with different-size needles are not a common technique in modern medicine.
Suture is the most popular method in clinic. Even when a few sutures
are broken, other nearby sutures are not affected, resulting in an absent of total
wound dehiscence. Suture are quick and easy to install and are generally nonallergenic. However, the disadvantages of sutures should be noticed. High
infection rate may be an urgent problem. They also require the use of anesthetic
and are a slow method of wound closure that is costly and difficult to master
for some practitioners (Quinn 2005). It may take a long time to heal by sewing.
Sutures can cause scars that may be of concern when the surgical site is on the
face or neck. Leakage of gas or fluid can lead to a serious failure. The use of
needles can cause many problems like anxiety and contaminations.
Therefore, alternatives to sutures are emerging for better wound care
in clinics. Staples, clips, and surgical tapes are the common alternative
techniques for wound closure including tissue adhesives. However, staples,
clips and tapes all have their disadvantages. Therefore, using tissue adhesives
to close and cure wounds has high possibility.
1.3.2

History and Background of Tissue Adhesives
The use of tissue adhesives for closing wounds may have more than a

thousand years. Due to the improvement of techniques and the shortcomings
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of common closure devices, investigation in tissue adhesives has gained
significantly since the middle of twentieth century. The sequential World Wars
stimulated the improvement of adhesives. Faced with large numbers of
casualties suffering severe blood loss, surgeons in World War I began to use
sheets of fibrin during surgery for the treatment of injuries (Sierra 1996). Many
effective, quick, and convenient adhesive products appeared in numerous
different types of surgery. In modern medicine, tissue adhesive has already
become an alternative method to seal wounds that are important in clinical
applications. Comparing to sutures and staples, the use of tissue adhesives
provides a fast bonding and fully closure.
1.3.3

Characteristics of Tissue Adhesives
The use of tissue adhesives has shown numerous benefits in both

clinical utilization and medical production. One of the advantages of tissue
adhesives is the prevention of leaking of air or fluid. The surgical site of any
vascular injury or a cavity organ surgery warrants an application for tissue
adhesives. The use of tissue adhesives does not need to remove sutures later.
There is also no risk of needle stick injury to the surgeon or assistant. Tissue
adhesives also provide the possibility of surgery without development of
scars after the healing process. The pinpricks of sutures make them a less
attractive choice consideration in plastic surgery. Tissue adhesives also
provide less time to heal comparing to sutures and significantly reduce the
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pain of suture. Tissue adhesives act as topical wound sealants to provide an
antimicrobial barrier to outside contamination, and to fixate structures where
sutures and normal fixation devices such as plates and screws cannot be used
(Quinn 2005). Most tissue adhesives are very convenient for clinical use and
can be performed with the assistance of a nurse without professional surgical
training. For example, some of them are applied in a matrix and can be
activated by mixing in the surgical site just prior to use. Also the cost of
tissue adhesives is not as expensive as sutures. With the enhancement of
medical technology, there will be more effective adhesives for more
extensive applications.
1.3.4

Classifications of Adhesives
Tissue adhesives in the United States can be categorized into five

groups. There are several commercial products already available in the market
for each category. Cyanoacrylate is the first one. They are not decomposed by
our body. Cyanoacrylates can induce internal inflammation, tissue necrosis,
and infection risks associated with foreign bodies (Reece 2001). Secondly,
fibrin sealants are comprised of thrombin and fibrinogen. Fibrin sealants are
biocompatible and biodegradable and they are not associated with
inflammation, foreign body reactions, tissue necrosis, or extensive fibrosis
(Ryou 2005, Spotnitz 2005). The composition of hydrogels is the third tissue
adhesive that can be broken down, but they may require long time for reaction
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under the conditions of light. Albumin-based compounds make the forth tissue
adhesive that are glutaraldehyde glues which contain two compounds, albumin
and crosslinker. BioGlue surgical adhesive is categorized in this group of tissue
adhesive which is a two-component system. The last group is collagen-based
adhesives. The composition is bovine collagen and bovine thrombin. This type
of tissue adhesives is relatively expensive because it is comparatively new and
more investigation may be needed for long-term effects.
1.3.5

Protein Based Tissue Adhesives
The benefits of using tissue adhesives has stimulated new approaches

and developments. The use of proteins in adhesives is not novel. Egg white
was used as a binding agent in ancient time (Quinn 2005). The use of proteins
in adhesives is when a protein polymer reacted with a crosslinking agent,
usually glutaraldehyde (GTA), to adhere to tissue surfaces. The most
significant difference of this class of adhesives and sealants from the fibrinthrombin-based sealants is their independence of the coagulation cascade
(Quinn 2005). Protein-based adhesives do not relate with coagulopathy or
anticoagulation. The GR-Dial (Fehling, Germany), FocalSeal (Focal Inc.,
Massachusetts, USA), and BioGlue (CryoLife Inc., NW Kennesaw, GA, USA)
are three examples for commercial tissue adhesives.
Protein-based tissue adhesives can be absorbed by human and animal
tissue during healing procedures. Proteins also have low toxicity but they are
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not without disadvantages. Premature dissolutions of the tissue adherences
frequently occurred due to enzymatic influence (Schwarz 1983). Proteins can
cause allergy for some infants and some adults. GTA as a crosslinker may need
more toxicological tests to be approved by Food and Drug Administration
(FDA). Avoiding these disadvantages and difficulties would be a significant
step forward for tissue adhesives. Proteins react with GTA to neutralize the
toxicological effects of GTA on human body to make GTA an appropriate
crosslinker.
1.3.6

Principles of Protein Based Adhesives
In this study, whey protein was used as protein polymer and GTA as a

crosslinker. The linear structure of oily transparent GTA is a 5-carbon
dialdehydes. GTA is a generally dependable material that invariably gives
high yields of immobilized protein on the support (Walt 1994). GTA was
used as a crosslinker in a tissue adhesive for hemostasis and urine leakage
and also for decreasing blood loss during kidney surgery.
The cross-linking of a protein-based tissue adhesive to itself and to
the tissue is the result of the reaction between the amine groups of tissue
proteins and the terminal aldehyde groups which are provide by the bifunctional reagent GTA (Quinn 2005). The amines for this reaction are
provided by the ε-amino groups of the side chains of lysine residues with εNH2 in albumin and extracellular matrix proteins from the tissues (Hewitt
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2001). Asparaginyl, glutaminyl, and arginyl residues also provide amino
groups crosslinked with GTA. The mechanism of reaction of GTA with BSA
and cell surface proteins to form dimers and polymers which is shown in
Figure 4 (Quinn 2005). Proteins are stable enough after reacting with GTA
which also has the function of immobilization. Proteins can form a soft and
ductile barrier moving with human body.
β-LG, α-LA, and BSA, respectively, contain 162, 123, and 583 total
amino acid residues. The numbers of ε-amino groups are 37, 27 and 113,
respectively, in these three proteins (Brew 1967, Hirayama 1990, Fox 2003).
There are enough functional ε-amino groups for bonding tissue together.
After bonding, the protein-based tissue adhesives can be degraded by
proteolysis.
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Figure 4. Mechanism of Reaction of GTA with BSA and Cell
Surface Proteins
1.3.7

Crosslinking Agents
The choice of protein crosslinking agents usually affects the efficiency,

toxicity, and bonding strength of tissue adhesives. There are usually three
options used as protein crosslinking agents. GTA is the first one used as a
cross-linking agent in tissue adhesives. BioGlue uses GTA as a crosslinker.
The advantage of this approach is in the preservation of functioning renal
tissue without compromising the oncologic outcome (Hidas 2006). GTA tissue
adhesive can be used for hemostasis and decreasing the blood loss during
nephron-sparing surgeries. The reaction of GTA with proteins is immediate,
reaching full bonding strength within 5 minutes. The use of this tissue adhesive
significantly reduced the volume and the rate of postsurgical bleeding, and
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occasionally the inflammatory response. Although GTA is wildely used in
many tissue adhesives, the toxicity of GTA should be noticed. GTA can cause
cytotoxic effects. Superior bonding and sealing capabilities to tissues as well
as to synthetic graft materials allowing air-tight and blood-tight repair
properties are claimed for BioGlue (Furst 2005).
Genipin is another type of crosslinking agents. Genipin can react with
chitosan and some peptides that contain primary amine groups. Genipin has
the advantages of high bonding strength and low toxicity. It has recently
provoked interest for its ability to crosslink chitosan and certain proteins
containing residues with primary amine groups, particularly, gelatin and soya
protein isolates (Butler 2003). Genipin can be widely used to crosslink gelatin
in the study of tissue sutures, soy protein isolates in food applications, and so
forth. The reason why genipin was used in these applications is that the
cytotoxicity is much lower than other cross-linking agents such as
glutaraldehyde. However, the bonding strength of genipin is not as sufficient
as compared to glutaraldehyde. The reaction time for reaching full bonding
strength between gelatin and genipin can be as long as 24 hours (Yao 2003).
Tartaric Acid Derivative (TAD) is relatively novel cross-linking agent
that is widely used in many fields. TAD was prepared by reacting carboxyl
groups of tartaric acid with N-hydroxysuccinimide in the presence of
carbodiimide (Iwasashi 2009). It can reach full bonding strength within 5
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minutes and the strength can be several times that of fibrin glue. TAD is an
organic acid that can shorten bonding time and also has adequate bonding
strength. TAD can be slowly dissolved and reacts with human serum albumin
solution. Tartaric acid can be derived from fruit extracts and TAD tissue
adhesives are less toxic. It has a limitation that rodent regeneration is better
than in human beings, and the period for gel absorption and wound healing
may differ in actual human use (Iwasashi 2009).
1.3.8

Testing of Tissue Adhesives
The physical bonding strength test is the primary test for evaluation

criteria of any tissue adhesive development. Lap-shear bonding strength is
tested for tissue adhesives according to the method of ASTM F2255-05. The
fresh porcine skin graft is cut into the size shown in Figure 5. The bonding
strength is tested by an Instron machine (Instron Corporation, Canton, MA,
USA). The stress is needed to break the joint at the maximum load (N).

Aluminum fixture

Porcine skin
10.16 cm

Bonding area

2.54 cm
1.00 cm

5.08 cm

Figure 5. Depiction of Lap-shear Bonding Strength Test Specimen
1.3.9

Application of Tissue Adhesives
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BioGlue®, a commercial tissue adhesive, is approved for clinical tissue
bonding and vascular sealing by the US Food and Drug Administration (FDA)
as a medical device. It has also been approved by the European Union and
elsewhere for extensive clinical use. The major components of BioGluee are
BSA (45%, w/v) as protein polymer and GTA (10% w/v) solution as
crosslinker (Quinn 2005). BioGlue is provided in a double-tube syringe that is
stored at temperature (23°C). The ratio of BSA and glutaraldehyde is four to
one. The syringe is inserted through an applicator which is shown in Figure 6.
During a surgery, the cover on the top of the syringe is removed and a sterilized
mixer is attached to the syringe ready for use. The compounds are mixed in the
mixer when the applicator is applied by pushing forth and back. The pre-filled
syringe is available in 2, 5, and 10 mL volumes for different requirements in
surgery (Quinn 2005).

A
B
C

Figure 6. Delivery System of Tissue adhesive
A: Dispensing gun, B: Dual barrel cartridge system (4:1), C: Static mixer
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BioGlue mainly contains albumin which can be degraded by
proteolysis. The resorption of BioGlue is slow. BioGlue was approved for
biocompatibility tests which contain toxicity, cytotoxicity, and mutagenicity
studies. The cost of BioGlue is from $50 to $135/ml depending on different
size (Quinn 2005).
If BSA is a suitable protein polymer for tissue adhesive, whey protein
that contains a group of globular proteins including BSA and a large number
of free amino groups, should be suitable for a tissue adhesive polymer as well.
WPI as a protein polymer may reach full bonding strength comparable as
BioGlue. Moreover, WPI is cheaper and more abundant than BSA. Also, the
model system can be sterilized by gamma radiation easily and effectively and
maintain aseptic.

1.4 GAMMA RADIATION
1.4.1

Overview of Gamma Radiation
The two types of radiation are electromagnetic and corpuscular.

Electromagnetic radiation consists of self-propagating electric and magnetic
disturbances (Urbain 1986). Corpuscular radiation contains massive particles
with energy. Gamma rays are electromagnetic radiation of nuclear origin with
short wavelengths in the region of 3 × 10-9 cm to 3 × 10-11 cm (Spinks 1976).
Gamma rays are high frequency and energy photons. Gamma radiation is
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ionizing so it is biologically hazardous. Gamma radiation is produced from
gamma decay and the energy is emitted from high energy stage to low energy
stage. When gamma radiation passes through matter, it is absorbed by
processes which set electrons in motion and these electrons produce ionization
of other atoms or molecules in the medium (Dendy 2012).
The absorbed energy from the radiation is the matter rather than
wavelength. The energy can be described by wavelength shown in the equation
where h is Planck’s constant, c is the velocity of light, and λ is the wavelength
(Spinks 1976). Cobalt-60 is a common source of radioactive isotope of gamma
radiation.
E=hc/λ
Gamma radiation is described by one of the units called gray (Gy).
Gamma radiation can cause damage at a cellular level such as skin burns. It
also causes damage like DNA damage, cell death, and increasing incidence of
cancer. Due to the protection of personnel safety away from hazard effects of
gamma radiation, it must be surrounded by enough thick walls made from high
density materials and is usually put underground. The properties of gamma
radiation can be exploited in many applications. For example, gamma radiation
can be used to kill microorganisms, to treat some types of cancer, and to form
diagnostic images.
1.4.2

Application of Gamma Radiation
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Food irradiation is another application of gamma radiation that
employs an energy form to treat foods for sterilization. Some ionizing radiation
is capable to pass through some foods. Through physical effects they interact
with the atoms and molecules that make up the food and also those of food
contaminants, causing chemical and biological consequences which can be
utilized in beneficial ways (Urbain 1986). Food irradiation benefits include
disinfection, inhibiting sprouting, and pathogen killing. Food irradiation also
prolongs the shelf life of foods and delays ripening.
Furthermore, gamma-irradiation generates sterile biomaterials which
could be used in pharmaceutical or biomedical applications (Ressouany
1998). In this study, gamma radiation was used to sterilize WPI solution as a
part of tissue adhesive. The ideal tissue adhesive would have at a minimum
the following capabilities which are safe and biodegradable, effective, easily
usable, affordable, and approvable by government regulatory agencies for use
in the United States (Sierra 1996). The sterilization of WPI solution is,
therefore, very important for the safety of protein-based tissue adhesives.
Thermal treatments, filtration, and irradiation are three commonly used
methods for sterilizing food products, but heating can cause protein
denaturation. Furthermore, WPI solutions in the desired range of
concentrations (27%-36%) are too viscous to be filter sterilized. Gamma
radiation may offer the only practical alternative method to sterilize WPI
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solutions. Gamma radiation may offer an alternative and practical method to
sterilize WPI solutions. However, gamma radiation can cause chemical and
physical changes that could functional affect properties of WPI solutions.
Chemical changes in the proteins caused by gamma-irradiation include
degradation, cross-linking, aggregation and oxidation by oxygen radicals that
are generated in the radiolysis of water (Lee 2005).
1.4.3

Interaction of Matter with Gamma Radiation
Gamma radiation interacts with orbital electrons of matter at the atomic

scale. The energy absorbed is related to the density, the atomic cross-section,
and thickness of the material. There are three situations including photoelectric
effect, Compton scatter, and pair production, as shown in Figure 7 (Faires
1981).
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Figure 7. Interaction of Gamma Rays. (a) Photoelectric Effect. (b)
Compton Scatter. (c) Pair Production
When an individual gamma photon interacts with a massive object,
such as shielding, the primary interaction takes place with one electron or the
nuclear field of a single atom (Faires 1981). An electron is ejected and passes
into the mass of the object where its energy is dissipated. In the photoelectric
effect, a gamma photon strikes an electron and the energy is transferred to the
electron and the photon is totally stopped. In Compton, scatter the photon
interacts with an atomic electron and enough energy is transferred to the
electron for the ejection from the atom (Faires 1981). The photon maintains
some energy to become a new photon with a different direction and lower
energy. The pair production situation happens at the absorption of a high
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energy gamma photon. The photon collides with the electric field of a nucleus
to generate a positron pair (Faires 1981). The ejected position will bump into
an electron and the annihilating process will generate two gamma photons.

1.5 OBJECTIVES
The objectives of this study were to develop a method to sterilize whey
protein solution using gamma radiation and to formulate a tissue adhesive
using whey protein as the major polymer.
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CHAPTER 2: MATERIALS AND METHODS

2.1 MATERIALS
WPI with a protein content of 90% was purchased from FonterraTM
(Auckland, New Zealand). Glutaraldehyde (GTA) (50%) was purchased from
Fisher Scientific Inc. (Pittsburgh, PA). Aerobe count and yeast and molds
count Petrifilms were purchased from the 3M™ Petrifilm™. Porcine skins
were purchased from a local supermarket. Pre-filled buffer (99 ml) was
purchased from Fisher Scientific Inc. (Pittsburgh, PA).

2.2 METHODS
2.2.1 Model System Preparation
Protein tissue adhesive was comprised of WPI solution and GTA
solution. WPI powder was dissolved in deionized water at concentrations of
27%, 30%, 33%, and 36% (w/w). The solutions were mixed with a blender for
15 minutes at 1000 RPM. WPI solutions were stored in a refrigerator at 4°C
overnight. Defoamed WPI solutions were poured into 10 ml centrifuge tubes
and labeled for protein concentrations and irradiated dosages. Various
concentrations of WPI solutions were treated by different dosages (10 – 25
KGy) of gamma radiation. Treatment of gamma radiation at different levels on
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protein solutions were shown in Table 4. The treated WPI solutions were stored
at room temperature. GTA (50%) was diluted with sterilized deionized water
to 6.0%, 8.0%, 10.0% and 12.0% (v/v).
Table 4. Treatment of Gamma Radiation on Different Levels of Protein
Solution
Sample ID

27%

30%

33%

36%

Protein
Dosage
10 KGy

S1-1

S1-2

S1-3

S1-4

12.5 KGy

S2-1

S2-2

S2-3

S2-4

15 KGy

S3-1

S3-2

S3-3

S3-4

17.5 KGy

S4-1

S4-2

S4-3

S4-4

20 KGy

S5-1

S5-2

S5-3

S5-4

25 KGy

S6-1

S6-2

S6-3

S6-4

2.2.2 Microbial analysis
Each sample (1 ml), respectively, was diluted to 10-1 with 9 ml sterile
buffer and another 1 ml of the sample was diluted to 10-2 with 99 ml sterile
buffer. 10-3 dilution was prepared by adding 1 ml 10-1 dilution to 99 ml of
sterile buffer. Each different dilution was applied on aerobe count and yeast
and molds count Petrifilms according to the manufacturer’s instructions.
Triplicates for each sample were tested for aerobe, yeast and molds. The top
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of films was lifted to expose the surface and 1 ml of each dilution (10-1, 10-2,
and 10-3) from each sample was added inside a circular foam barrier on Aerobe
count Petrifilms and yeast and molds count Petrifilms. The petrifilm has a
circular bottom with a barrier and a top to enclose the sample within the
Petrifilm. Petrifilms were gradually rolled down and distributed evenly by a
plastic spreader and gas bubbles were excluded by this process. WPI solutions
prior to gamma radiation treatment were also tested by aerobe count and yeast
and molds Petrifilms. After a few minutes of drying, aerobe count Petrifilms
were put into incubator at 37°C for 48 hours and yeast and molds count
Petrifilms were put at room temperature for at least 48 hours. The readable
plate count for Petrifilm is between 25 to 250 colonies forming units or CFUs.
There will be splotches or spots surrounded by bubbles for molds if there are
CFUs present.
2.2.3 Viscosity
Apparent viscosity of various concentrations of WPI solutions before
and after irradiation at various dosages was determined at room temperature
(23°C) using a Viscometer (Model DV-I Prime, Brookfield Engineering Labs
Inc., Stoughton, MA, USA). Samples were tested with spindle # 3 at 100
RMP. The viscosity reading on the screen was recorded after the spindle has
been activated for 20 seconds. Three replicates were performed for each
sample.
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2.2.4 Gelation during Storage
Gelation was observed every other week during the storage. If the
WPI solutions showed solidifying properties then they are not suitable for
use of tissue adhesives.
2.2.5 Soluble Nitrogen
The pH 4.6-soluble nitrogen of WPI solutions was tested by the method
of International Dairy Federation (IDF 1964a). Four ml samples of each
combination were weighed, respectively, and added into 10 ml centrifuge tubes.
Four ml of distilled water was transferred into each tube. Acetic acid (10%,
v/v, 0.4 ml) was added into every tube, mixed and kept for 10 minutes. Na
acetate (1M, 0.4 ml) was added into every tube and mixed gently. All tubes
were volumed up to 10 ml with deionized water. Total sample of mixture was
filtrated through Fisher Q 8 filter paper. The precipitate was removed and a
sample (2 ml) of filtrate was taken for nitrogen determination by the Kjeldahl
method.
2.2.6 Lap-shear Bonding strength
Lap-shear bonding strength was measured with the method of ASTM
standard (ASTM 2005). Fresh porcine skin was cut into 5.08 cm × 2.54 cm
pieces with a No. 15 UnibladeTM surgical scalpel (AD Surgical, Sunnyvale,
CA, USA). Two skin strips were adhered on two aluminum blocks with dermal
side up with Gorilla® super glue (The Gorilla Glue Company, Cincinnati, OH,
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USA). The test specimens were kept moist by wrapping with gauzes soaked
with phosphate buffered saline (PBS) (Fisher Scientific, Fair Lawn, NJ, USA)
and placed in an environmental chamber at 25 °C. 80 µl of WPI solution and
20 µl of GTA solution were applied on the skin dermal side and mixed with a
small steel spatula and then the two porcine skin strips were lapped together
by the fixture as showed in Figure 5. The bonding area was 2.54 cm × 1.0 cm.
Glued specimens were kept for 30 min and tested by an instron 5566 machine
(Instron Corporation, Norwood, MA, USA). Specimens were put tightly in the
loading cell of the Instron and the test was started until the two porcine skin
stripes separated. The maximum load (N) was recorded and the bonding
strength (kPa) was calculated. The bonding strength (36% protein, 10% GTA)
was also compared with a commercial tissue adhesive.
2.2.7 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
SDS-PAGE was conducted with separating and stacking gels
according to the method of Guo et al. (Guo 1995). The glass plate
sandwiches were assembled and sealed with Vaseline. Total volume of 80 ml
sample buffer, separating gel, and stacking gel were prepared. 50μl sample
were added into 10 ml sample buffer and mixed well. Equal amounts of
samples were loaded on each lane for comparison. SDS-PAGE was
performed at a constant current of 150 V for 10 minutes at 60 mA and then at
200 V mA at 25 mA for an additional 30-40 minutes at room temperature.
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Gels were fixed with 25% (v/v) propan-2-ol and 10% glacial acetic acid
overnight. Gels were stained with stained buffer and stored at room
temperature for 5 hours. Then the gels were disdained with distained buffer
for 2-3 hours until the blue color was washed off to make the gels transparent
and the bands clearly visible.
2.2.8 Scanning Electron Microscopy (SEM)
On two separate occasions, scanning electron microscopy (SEM) was
for analyzing the microstructure of WPI solutions. For the first trial, whey
protein adhesives were prepared by loading in an applicator to mix and
spread the components. The material was extruded out onto a piece of
parafilm and cured at room temperature. Then the material was frozen in
liquid nitrogen and fractured. The pieces were mounted on aluminum stubs
with silver conductive paste and carbon coated and then sputter coated with
Au/Pd (approximately 4 nm) (Hendricks 1983). Treated samples before and
after irradiation were then scanned on a FEI Quanta 200 FEG ESEM Mark II
scanning electron microscope (UMASS, Worcester, MA, USA) at an
accelerating electron voltage of 10 kV. Images were recorded at 25,000 X
magnifications. Second trial, SEM images were obtained at the University of
Vermont. Samples were dehydrated and obtained at 10,000X magnifications.
All images were recorded digitally using Scandium software (Olympus
Corporate, Germany).
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2.2.9 Statistical Analysis
SPSS® Version 21 software for Linux (SPSS Inc., Chicago, IL, USA)
was used for statistical analysis. The data were analyzed by ANOVA which
analyzes the effects of gamma radiation treatment and storage time. Significant
differences between group means of the variations were observed in
partitioned components. The p-value less than 0.05 is considered as significant
differences.
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CHAPTER 3: RESULTS AND DISCUSSION

3.1. RESULTS AND DISSCUSSION
3.1.1 Effect of Radiation on Microbial Properties
The WPI solutions were tested for aerobic microorganisms and yeast
and molds by 3M™ Aerobic Count Petrifilm™ and Yeast and Molds
Petrifilm™, respectively, for six months after gamma radiation treatment (1025 KGy). No microorganism have been found during these six months for
treated samples in both aerobic count Petrifilms and yeast and molds Petrifilms.
The smallest dosage (10 KGy) of gamma radiation that was applied in this
study sufficient to sterilize WPI solutions and to eliminate the presence of
viable microorganisms. The tests for aerobic bacteria and yeast and molds
before the treatment of gamma radiation were also conducted in Chinese
Academy of Agricultural Sciences, Beijing, China. The colonies on aerobic
count Petrifilms were 107, 43, and 93 for 10-1 dilution so the mean result was
810 CFU/ml and the yeast and molds Petrifilms showed that the mean result
was 200 CFU/ml.
WPI was dissolved with deionized water and stored at room
temperature (23°C). The conditions, which include water activity, temperature,
oxygen, food, and acidity, are suitable for aerobic mesophilic bacteria to
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generate and grow. Aerobic count Petrifilms were incubated for 48 hours at
35°C and Yeast and Molds Petrifilms were incubated for 48-96 hours at room
temperature that created optimum conditions. Similar as incubation conditions,
microorganisms have not grown or generated during six-month storage. Spores,
which are formed in unfavorable conditions and are able to develop into new
organisms under favorable conditions, did not grow and generate in the
systems.
3.1.2 Viscosity
Viscosity is a measurement of pressure which comes from interactions
or collisions of particles moving in different directions and velocities in fluid.
Technically, with regard to homogeneous solution the higher concentration of
the solution, the higher viscosity the fluid shows. Temperature significantly
impacts viscosity. In this study, the temperature was kept constant at room
temperature to eliminate interference.
The viscosity was used to measure the effects of gamma radiation on
polymerization of WPI solutions. The viscosity of WPI solutions was
influenced by the treatment of various dosages of gamma radiation. The
viscosity before and after gamma radiation treatment was shown in Figure 8.
The viscosity of protein solution (27%, w/w) was increased from 2.19 for the
control to 4.78 mPa·s for the sample treated at 25 KGy, respectively. For
30% protein solution, the viscosity was increased from 4.87 for the control to
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12.72 mPa·s for the sample treated at 25 KGy. The viscosity of protein
solution (33%) was 11.2 for the control and then decreased to 10.14 and
11.15 mPa·s at 10 KGy and 12.5 KGy but increased over 15 KGy. For
protein solution (36%), the viscosity was from 10 KGy to 15 KGy and then
increased to 71.6 mPa·s at 25 KGy. Gamma radiation has the effects of
fragmentation and aggregation. Proteins can be converted to higher
molecular weight aggregates, due to inter-protein cross-linking reactions,
hydrophobic and electrostatic interactions, as well as the formation of
disulfide bonds (Davies 1987, Lee 2005). However, at low dosage, gamma
radiation exhibits the effect of fragmentation. Figures 9 to 12 also show the
viscosity was increased during storage for six months after gamma radiation.
3.1.3 Gelation
WPI solutions were treated by the highest dosage of gamma radiation.
As long as WPI solutions begin to gel, they are not used for tissue adhesives
any more. Protein solutions (27%) treated by 25 KGy gelled within sixmonth storage. Protein solutions (30 and 33%) treated by 15, 17.5, 20, 25
KGy all gelled. Protein solutions at 36% treated by 15, 17.5, 20, 25 KGy
gelled in first 3 months. The one treated by 12.5 KGy got gelled in fifth
month.
3.1.4 Soluble Nitrogen
Gamma radiation affects functional and structural properties of
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proteins including nitrogen solubility. Soluble nitrogen also measures the
effects of gamma radiation on polymerization of WPI solutions. The nitrogen
solubility was decreased by gamma radiation due to protein-based
conformational modification, shown in Figure 13. The soluble nitrogen (10%,
w/w) was decreased from 100% to 54.7% for the untreated sample and the
sample treated at 35 KGy. The statistical analysis of soluble protein indicated
that radiation treatment had significant impact on soluble nitrogen of whey
protein solutions (p<0.05).
3.1.5 Lap-shear Bonding Strength
Protein/ glutaraldehyde tissue adhesive was tested for bonding strength
at the first week after gamma radiation treatment. On two different occasions,
bonding strength was tested every other two month. Glutaraldehyde (8% and
10%) which was used as a crosslinking agent in this study reacted with various
concentrations of WPI solutions before and after gamma radiation treatment.
The results for bonding strength are shown in Figures 14, 15, and 16.
For the same whey protein solution, bonding strength was generally
increased with increasing dosage of gamma radiation and also with increasing
concentration of GTA. However, bonding strength is influenced by many other
factors during the operation. For instance, after mixing WPI solution and
glutaraldehyde, the tissue adhesive may flow away from the bonding area
before solidification which may decrease the bonding strength.
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Generally, providing the same percentage of glutaraldehyde, higher
dosage of gamma radiation leads to higher bonding strength. Higher
concentration of protein also increases the bonding strength. Increasing the
percentage of protein also provides a method to enhance bonding strength
when the concentration of glutaraldehyde and the dosage of gamma radiation
remain constant.
During storage, bonding strength showed increasing. The 33% protein
with 10% and 12% glutaraldehyde with 12.5 KGy gamma radiation bonding
strength were 20.69 and 23.61 N, respectively. The results of bonding strength
(36% protein) and commercial tissue adhesive are shown in Figure 17. The
fifth month bonding strength was comparable to the commercial tissue
adhesive. Overall, bonding strength increases during storage at room
temperature. We conclude that, WPI solutions start to gel during storage. If
gelation has already begun before gamma irradiation, proteins may be
polymerized and denatured which can cause a lack functional and structural
properties.
3.1.6 Protein Profile
Polymerization caused by gamma radiation was also used SDS-PAGE
to determine. On the base of electrophoretic mobility, proteins are conformed
to several lines on the gel depending on their molecular weight. Sodium
dodecyl sulfate (SDS) is used to form linear-structural proteins and cause a
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negative charge so that proteins migrate from negative electrode to positive
electrode.
Protein profiles of WPI solution were shown in Figure 18. The SDSPAGE profiles (10% and 30%) both show that proteins were cross-linked in
the samples treated by gamma radiation under the same amount of samples.
The protein profiles show non-quantitatively that proteins were aggregated to
higher molecular weights than samples untreated by gamma radiation. Any
amino acid radical that is formed within a peptide chain could cross-link with
an amino acid radical in another protein (Lee 2005).
3.1.7 Microstructure
Micrographs of the treated WPI solution was shown in Figures 19 and
20. In Figure 19, treated sample (A) has disorder and non-regular pattern
structure. It seems protein structure was fragmented by gamma radiation and
produced some voids. In contrast, untreated sample (B) had clean bands. In
Figure 20, treated protein bands were smeared.
Gamma radiation has two diametrically opposite effects on whey
proteins aggregation and fragmentation. However, by high dosage of gamma
radiation treatment, conformation of protein is generally aggregated to form
high molecular weight.

3.2 FUTURE WORK
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Future work for this project would work on optimal dosage of gamma
radiation to sterilize the model system and inhibit the growth of
microorganisms for at least six months. This dosage should also have the
minimal effects on protein-based functional and structural properties of whey
protein.
Next attempts may be in the range from 30% protein to 45% protein.
BioGlue has 45% BSA as a polymer.
Toxicological evaluations should also be included for the development
of protein/glutaraldehyde tissue adhesives. Glutaraldehyde has been
mentioned previously for its known toxicity. The percentage of glutaraldehyde
did not only affect bonding strength, but also is a significant factor for
toxicological testing. Animal experiments may be needed before the product
enters human trial phases.
After sterilizing WPI solutions by gamma radiation, gelation may be a
factor that affected shelf life. To extend shelf life of this development,
preventing from gelation is essential. Other than the dosage of gamma
radiation, gelation inhibitor or an appropriate procedure may be an alternative
to slow down gelling for future work.

3.3 CONCLUSIONS
Gamma radiation may cause protein-protein interactions resulting in
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increase in viscosity, and bonding strength, decreasing pH 4.6 soluble N.
Results indicated that gamma radiation may be suitable for sterilizing the
protein based adhesive system.
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Figure 8. Effect of Gamma Radiation on Viscosity of WPI Solutions
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Figure 9. Changes in Viscosity of WPI Solution (27%) during Storage
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Figure 10. Change in Viscosity of WPI Solution (30%) during Storage
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Figure 11. Change in Viscosity of WPI Solution (33%) during Storage
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Figure 12. Change in Viscosity of WPI Solution (36%) during Storage
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Figure 13. Effect of Gamma Radiation on Soluble Nitrogen of WPI
Solution (10%)
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Figure 14. Effects of Gamma Radiation on the First Month Bonding
Strength of WPI Solutions with Different Level of GTA
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Figure 15. Effects of Gamma Radiation on the Third Month Bonding
Strength of WPI Solutions with Different Level of GTA
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Figure 17. Comparison of commercial tissue adhesive with 36% protein
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Figure 18. SDS-PAGE Photographs of Whey Protein Profile before and
after Radiation at Different Dosage (0-25 KGy) 0f 10% and 30% WPI
Solution
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Figure 19. Comparison of SEM Images of WPI Solutions (30% protein)
before and after Gamma Radiation Treatment. A: WPI Solution
Untreated at 10K Times; B: WPI Solution Treated by 15 KGy at 10,000
X Mag
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Figure 20. SEM Images of WPI Solutions (30% protein) Treated by 0
KGy (A), 10 KGy (B), 12.5 KGy (C), and 20 KGy (D) Gamma Radiation
at 25,000 X Mag
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